Dasiglucagon Hydrochloride Patent Expiration

Dasiglucagon Hydrochloride is Used for managing low blood sugar levels in diabetic patients. It was first introduced by Zealand Pharma Us Inc in its drug Zegalogue on Mar 22, 2021. Another drug containing Dasiglucagon Hydrochloride is Zegalogue (Autoinjector).


Dasiglucagon Hydrochloride Patents

Given below is the list of patents protecting Dasiglucagon Hydrochloride, along with the drug name that holds that patent and the company name owning that drug.

Drug Used in Drug Patent Number Drug Patent Title Drug Patent Expiry Drug Owner
Zegalogue US10442847 Glucagon analogues Feb 03, 2035 Zealand Pharma
Zegalogue US11795204 Glucagon analogues Jan 06, 2034 Zealand Pharma
Zegalogue (autoinjector) US10442847 Glucagon analogues Feb 03, 2035 Zealand Pharma
Zegalogue (autoinjector) US11795204 Glucagon analogues Jan 06, 2034 Zealand Pharma


A patent's expiry date may change depending upon legal activities going on that patent. Critical activities like abandoning of a patent, term extension of a patent or amendment of its claims can increase or decrease the life of a patent hence affecting its expiry date and in turn affecting the generic launch date of that drug. Tracking these ongoing activities on a patent application helps to keep an eye on the latest developments in the patent process of the drug which can give an idea of how early a drug's generic could be available. The next section provides a list of recent legal activities on Dasiglucagon Hydrochloride's patents.

Given below is the list recent legal activities going on the following patents of Dasiglucagon Hydrochloride.

Event Date Patent/Publication
Patent litigations
Mail Patent eCofC Notification 25 Jun, 2024 US11795204
Email Notification 25 Jun, 2024 US11795204
Patent eCofC Notification 25 Jun, 2024 US11795204
Recordation of Patent eCertificate of Correction 25 Jun, 2024 US11795204
Post Issue Communication - Certificate of Correction 05 Jun, 2024 US11795204
transaction for FDA Determination of Regulatory Review Period 30 Nov, 2023 US10442847
Email Notification 24 Oct, 2023 US11795204
Patent Issue Date Used in PTA Calculation 24 Oct, 2023 US11795204
Mail Patent eGrant Notification 24 Oct, 2023 US11795204
Recordation of Patent eGrant 24 Oct, 2023 US11795204



Coming Soon

Patent Strength Analyzer

Will this be useful for you?

YesNo

Thank you for your response 🥳